All In MedTech

FDA Clearance Tracker · K152299

TBS iNsight

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 29, 2016 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Apr 29, 2016

Substantially Equivalent

Time to decision

260 days

Received Aug 13, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K152299
Device name
TBS iNsight
Applicant location
Plan Les Ouates, CH
Received
Aug 13, 2015
Decided
Apr 29, 2016
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 892.1170

Every decision under product code KGI

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code KGI. The earliest in FDA's data is K792444, decided Dec 27, 1979.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Medimaps Group SA

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.